logo

For the Inventor, By the Inventor

Mannheim, Germany

Lothar Kling

This inventor holds 17 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Hoffmann-La Roche Inc., Boehringer Mannheim Gmbh, Roche Diagnostics Gmbh. Active years: 1983-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lothar Kling. Retrieved from https://idiyas.com/inventor/lothar-kling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17

% Patents Active = 64.7

Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 228(Granted Patents)


Location History:

  • Wiesbaden, DE (1983)
  • Mannheim, DE (1989 - 2011)

Company Filing History:

goldMedal6 out of 5,027 
 
Hoffmann-La Roche Inc.
 patents
silverMedal5 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents
bronzeMedal3 out of 489 
 
Roche Diagnostics Gmbh
 patents
4. 1 out of 1 
 
Prof. Dr. Wolf-Georg Forssmann
 patent
5. 2 out of 834,601 
Other
 patents

Years Active: 1983-2011

Loading Chart...
Areas of Expertise:
Pyridyl Sulfonamide
Amino Alcohol Derivatives
Osteoblast Mitogens
Phenylpyridine
Thioether Derivatives
Heterocyclic Compounds
Peptides
Plasminogen Activators
Cadherin Derived Growth Factor
Drugs
Pharmaceutical Agents
Injection Devices
17 patents (USPTO):Explore Patents
1. 7939532 - Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents (2011-05-10),
2. 7879884 - Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents (2011-02-01),
3. 7625896 - Pyridylsulfonamide derivatives (2009-12-01),
4. 7429605 - Phenylpyridine derivatives (2008-09-30),
5. 7405231 - Oxidized thioether derivatives (2008-07-29),
6. 7005526 - Thioether derivatives (2006-02-28),
7. 6911553 - Osteoblast-specific mitogens and drugs containing such compounds (2005-06-28),
8. 6809175 - Cadherin derived growth factor and its use (2004-10-26),
9. 6444832 - Amino alcohol derivatives, method of producing said derivatives and medicaments containing them (2002-09-03),
10. 6429288 - Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds (2002-08-06),
11. 6197759 - Osteoblast-specific mitogens and drugs containing such compounds (2001-03-06),
12. 5888967 - Use of plasminogen activators to stimulate local bone growth (1999-03-30),
13. 5486530 - Use of torasemide for the treatment of brain oedemas (1996-01-23),
14. 4925845 - 2 heteroaryl 3,3 dialkyl-5-(3 oxo-2,3,4,5 tetrahydro-6 (1990-05-15),
15. 4882342 - 5-alkylbenzimidazoles, method of use and pharmaceutical compositions (1989-11-21),

Title: Lothar Kling: Innovator in Pharmaceutical Chemistry

Introduction

Lothar Kling is a distinguished inventor based in Mannheim, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 17 patents. His work primarily focuses on the development of novel compounds that have potential applications in the treatment and prevention of serious illnesses, including cancer.

Latest Patents

Among his latest patents are the "Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents." This invention encompasses compounds that are designed to be effective in controlling or preventing illnesses such as cancer. Another notable patent is the "Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents," which similarly aims to provide innovative solutions in the pharmaceutical industry.

Career Highlights

Lothar Kling has had a remarkable career, working with prominent companies such as Hoffmann-La Roche Inc. and Boehringer Mannheim GmbH. His expertise in pharmaceutical development has led to advancements that benefit both the medical community and patients worldwide.

Collaborations

Throughout his career, Lothar has collaborated with notable colleagues, including Wolfgang Von Der Saal and Angelika Esswein. These partnerships have fostered an environment of innovation and creativity, contributing to the success of his projects.

Conclusion

Lothar Kling's contributions to pharmaceutical chemistry through his numerous patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments, particularly in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…